Biomarkers and signaling analysis of postoperative delirium: a study based on metabolomics and proteomics

Status

Active, not recruiting

Phases

Early Phase 1

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR1900027276

Enrollment

Unknown

Registered

2019-11-07

Start date

2019-11-15

Completion date

Unknown

Last updated

2019-11-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Delirium

Interventions

Postoperative delirium group:NA

Postoperative non-delirium group:NA

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1) older than 18; 2) patients returning to the ward after elective surgery; 3) CAM positive patients; 4) CAM scale is larger than 19 points; 5) sign informed consent voluntarily.

Exclusion criteria

Exclusion criteria: 1) Serious cardiovascular adverse events occurred during the operation; 2) Transferred to ICU immediately after surgery; 3) Communication disorders, inability to cooperate with researchers, such as language comprehension disorders, mental disorders, etc. 4) Serious cardiovascular and cerebrovascular diseases; 5) Refusal to participate in the trial; 6) Halfway out of the test;

Design outcomes

Primary

Measure	Time frame
metabolomics studies;proteomics studies;	—

Secondary

Measure	Time frame
Stay in Hospital;Hospitalization cost;Side effects;1-year survival rate;	—

Countries

China

Contacts

Public ContactWei Zhang

Henan Provincial People's Hospital

hnsrmyyyljd@163.com+86 13838299702

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026